Session XV: Emerging Targets in GI Cancer

Chair(s)

• 

  Fatima Carneiro, MD, PhD

  Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP)
  Porto, Portugal
• 

  Eric Van Cutsem, MD, PhD

  University Hospitals Leuven / KU Leuven
  Leuven, Belgium

Presentations:

• 09:30 – 09:50 CEST

  Targeting RAS Mutations
  

  Speaker: John Strickler, MD – Duke University
• 09:50 – 10:10 CEST

  Targeting the HER2 Pathway in GI Cancer
  

  Speaker: Valentina Gambardella, MD, PhD – Hospital Clínico Valencia
• 10:10 – 10:30 CEST

  Targeting Claudin 18.2 in GI Cancer
  

  Speaker: Radka Obermannova, MD, PhD – Masaryk Memorial Cancer Institute and Masaryk University